Moderna raises over $600-million through IPO, falls below IPO price

Biotech company Moderna raised above $600 million on Thursday by selling about 26 million of its common stock at $23 a share, thus bringing its market cap to about $7.5 … Continue reading Moderna raises over $600-million through IPO, falls below IPO price